EG20096A - Process for preparing of peptides and mixtures thereof for detecting antibiotics to hepatitis C virus (HCV) - Google Patents
Process for preparing of peptides and mixtures thereof for detecting antibiotics to hepatitis C virus (HCV)Info
- Publication number
- EG20096A EG20096A EG40192D EG40192D EG20096A EG 20096 A EG20096 A EG 20096A EG 40192 D EG40192 D EG 40192D EG 40192 D EG40192 D EG 40192D EG 20096 A EG20096 A EG 20096A
- Authority
- EG
- Egypt
- Prior art keywords
- hcv
- hepatitis
- peptides
- virus
- mixtures
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/681,701 US5574132A (en) | 1991-04-05 | 1991-04-05 | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
Publications (1)
Publication Number | Publication Date |
---|---|
EG20096A true EG20096A (en) | 1997-07-31 |
Family
ID=24736406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG40192D EG20096A (en) | 1991-04-05 | 1992-04-01 | Process for preparing of peptides and mixtures thereof for detecting antibiotics to hepatitis C virus (HCV) |
Country Status (12)
Country | Link |
---|---|
US (1) | US5574132A (fr) |
EP (1) | EP0507615A1 (fr) |
JP (2) | JP3477198B2 (fr) |
CN (1) | CN1051091C (fr) |
AU (1) | AU1447492A (fr) |
CA (1) | CA2107672C (fr) |
EG (1) | EG20096A (fr) |
IE (1) | IE921070A1 (fr) |
IL (1) | IL101425A0 (fr) |
NZ (1) | NZ242183A (fr) |
WO (1) | WO1992017493A2 (fr) |
ZA (1) | ZA922309B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683864A (en) * | 1987-11-18 | 1997-11-04 | Chiron Corporation | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
US5350671A (en) * | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
US5712087A (en) * | 1990-04-04 | 1998-01-27 | Chiron Corporation | Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens |
DK0556320T3 (da) * | 1990-11-07 | 1999-10-18 | Abbott Lab | Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf |
GB9105871D0 (en) * | 1991-03-20 | 1991-05-08 | Inst Cientifico Tecnol Navarra | Synthetic peptides |
RU2148587C1 (ru) | 1991-06-24 | 2000-05-10 | Чирон Корпорейшн | Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа |
DE4209215A1 (de) | 1991-07-04 | 1993-01-07 | Boehringer Mannheim Gmbh | Hcv peptidantigene und verfahren zur bestimmung von hcv |
WO1993011158A2 (fr) * | 1991-12-06 | 1993-06-10 | Akzo Nobel N.V. | Peptides non-a, non-b |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
US6165730A (en) * | 1992-03-06 | 2000-12-26 | N.V. Innogenetics S.A. | Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
DE4240980A1 (de) * | 1992-08-07 | 1994-02-10 | Boehringer Mannheim Gmbh | HCV Peptidantigene und Verfahren zur Bestimmung von HCV |
KR100312535B1 (ko) * | 1993-04-30 | 2002-06-20 | 성재갑 | 혼합항원을이용한씨(c)형간염바이러스의항체진단방법 |
ATE249838T1 (de) * | 1993-05-12 | 2003-10-15 | Chiron Corp | Konserviertes motiv der hepatitis c virus e2/ns1 region |
JPH07135981A (ja) * | 1993-05-28 | 1995-05-30 | Eisai Co Ltd | 非a非b型肝炎ウイルス遺伝子に由来するdna及び構成ポリペプチド |
US5514539A (en) * | 1993-06-29 | 1996-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
AU8003894A (en) * | 1993-10-29 | 1995-05-22 | Srl Inc. | Antigen peptide compound and immunoassay method |
SE503627C2 (sv) * | 1993-12-27 | 1996-07-22 | Euro Diagnostica Ab | Peptid, diagnostiskt antigen och förfarande för hepatit C diagnos |
CA2172305A1 (fr) * | 1995-03-30 | 1996-10-01 | Muneo Aoyama | Peptide antigenique multiple, renfermant au moins deux peptides associes du virus de l'hepatite c |
US5849800A (en) * | 1997-03-28 | 1998-12-15 | The Penn State Research Foundation | Use of amantadine for treatment of Hepatitis C |
US5977299A (en) * | 1997-04-07 | 1999-11-02 | Dade Behring Marburg Gmbh | Activated peptides and conjugates |
US6030771A (en) | 1997-08-25 | 2000-02-29 | Centers For Disease Control And Prevention | Mosaic protein and restriction endonuclease assisted ligation method for making the same |
KR100847586B1 (ko) * | 1998-07-30 | 2008-07-22 | 가부시끼가이샤 센단세메이가가꾸겐큐죠 | C형 간염 바이러스의 측정방법 |
US7091324B2 (en) | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
US6210908B1 (en) | 1998-11-11 | 2001-04-03 | Dade Behring Marburg Gmbh | Activated peptides and conjugates |
AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
EP1256348B1 (fr) * | 2000-02-14 | 2012-05-02 | Mitsubishi Tanabe Pharma Corporation | Remedes contre l'hepatite c |
ATE303597T1 (de) * | 2000-07-07 | 2005-09-15 | Medmira Inc | Hcv mosaik antigen zusammensetzung |
AU2002259130A1 (en) * | 2001-05-03 | 2002-11-18 | Eli Lilly And Company | Agents for treatment of hcv and methods of use |
CA2540858C (fr) * | 2003-10-14 | 2009-12-08 | Intermune, Inc. | Acylsulfonamides et acides carboxyliques macrocycliques utilises en tant qu'inhibiteurs de la replication du virus de l'hepatite c |
CN103159853A (zh) * | 2013-02-23 | 2013-06-19 | 浙江家和制药有限公司 | 全人源抗丙型肝炎病毒核心抗原的基因工程Fab抗体及其制备方法和应用 |
WO2014183109A1 (fr) * | 2013-05-10 | 2014-11-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions et procédés de détection simultanée de l'antigène/anticorps du vhc |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464474A (en) * | 1980-07-09 | 1984-08-07 | Connaught Laboratories Limited | Non-A, non-B hepatitis assay and vaccine |
US5032511A (en) * | 1987-03-31 | 1991-07-16 | Mitsubishi Kasei Corporation | DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens |
JPS6490197A (en) * | 1987-09-30 | 1989-04-06 | Mitsubishi Chem Ind | Peptide |
GB2212511B (en) * | 1987-11-18 | 1992-01-22 | Chiron Corp | Hepatitis c virus |
DE3886363T3 (de) * | 1987-11-18 | 2004-09-09 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | NANBV-Diagnostika |
US5191064A (en) * | 1988-09-30 | 1993-03-02 | The Research Foundation For Microbial Diseases (Osaka University) | Non-a, non-b hepatitis virus antigen peptide |
JPH02167081A (ja) * | 1988-12-21 | 1990-06-27 | Tetsuo Nakamura | 非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質 |
WO1990011089A1 (fr) * | 1989-03-17 | 1990-10-04 | Chiron Corporation | Diagnostics et vaccins de nanbv (virus de l'hepatite non a, non b) |
DE69033891T2 (de) * | 1989-05-18 | 2002-08-29 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus |
EP0416725A3 (en) * | 1989-07-14 | 1991-03-20 | Chugai Seiyaku Kabushiki Kaisha | Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production |
ES2110411T3 (es) * | 1989-08-25 | 1998-02-16 | Chiron Corp | Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t. |
CA2065287C (fr) * | 1989-09-15 | 1999-12-21 | Tatsuo Miyamura | Isolats hvc nouveaux |
CA2032907C (fr) * | 1989-12-22 | 2002-05-14 | Richard R. Lesniewski | Test pour la recherche du virus de l'hepatite c |
EP0435229A1 (fr) * | 1989-12-27 | 1991-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | ADN d'un gène du virus de l'hépatite non-A non-B, son clonage et utilisation |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
EP0445801A3 (en) * | 1990-03-08 | 1992-07-01 | Kuraray Co., Ltd. | Peptide and its use |
KR100206150B1 (ko) * | 1990-04-04 | 1999-07-01 | 로버트 피. 블랙버언 | 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체 |
ES2152922T3 (es) * | 1990-04-06 | 2001-02-16 | Genelabs Tech Inc | Epitopos del virus de la hepatitis c. |
CA2047792C (fr) * | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Peptides synthetiques specifiques pour la detection des anticorps diriges contre le vhc, diagnostic de l'infection a vhc et sa prevention grace a des vaccins |
JP3114731B2 (ja) * | 1990-08-14 | 2000-12-04 | 国立感染症研究所長 | C型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法 |
DE59109221D1 (de) * | 1990-11-03 | 2001-11-15 | Dade Behring Marburg Gmbh | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung |
-
1991
- 1991-04-05 US US07/681,701 patent/US5574132A/en not_active Expired - Lifetime
-
1992
- 1992-03-30 ZA ZA922309A patent/ZA922309B/xx unknown
- 1992-03-31 IL IL101425A patent/IL101425A0/xx unknown
- 1992-03-31 NZ NZ242183A patent/NZ242183A/en unknown
- 1992-04-01 EG EG40192D patent/EG20096A/xx active
- 1992-04-03 JP JP50679992A patent/JP3477198B2/ja not_active Expired - Fee Related
- 1992-04-03 CA CA002107672A patent/CA2107672C/fr not_active Expired - Fee Related
- 1992-04-03 IE IE107092A patent/IE921070A1/en unknown
- 1992-04-03 WO PCT/CA1992/000137 patent/WO1992017493A2/fr active Application Filing
- 1992-04-03 EP EP92302975A patent/EP0507615A1/fr not_active Withdrawn
- 1992-04-03 AU AU14474/92A patent/AU1447492A/en not_active Abandoned
- 1992-04-04 CN CN92102356A patent/CN1051091C/zh not_active Expired - Fee Related
-
2001
- 2001-08-22 JP JP2001251465A patent/JP2002128798A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU1447492A (en) | 1992-11-02 |
JP3477198B2 (ja) | 2003-12-10 |
CN1065867A (zh) | 1992-11-04 |
CA2107672C (fr) | 2002-11-26 |
IL101425A0 (en) | 1992-11-15 |
CA2107672A1 (fr) | 1992-10-06 |
JPH06506669A (ja) | 1994-07-28 |
ZA922309B (en) | 1992-12-30 |
CN1051091C (zh) | 2000-04-05 |
WO1992017493A3 (fr) | 1992-12-10 |
NZ242183A (en) | 1994-03-25 |
WO1992017493A2 (fr) | 1992-10-15 |
US5574132A (en) | 1996-11-12 |
EP0507615A1 (fr) | 1992-10-07 |
JP2002128798A (ja) | 2002-05-09 |
IE921070A1 (en) | 1992-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG20096A (en) | Process for preparing of peptides and mixtures thereof for detecting antibiotics to hepatitis C virus (HCV) | |
GB2272443B (en) | Nucleotide and amino acid sequences of Korean hepatitis C virus | |
GB2239245B (en) | Post-transfusional non-A non-B hepatitis viral polypeptides | |
HK38293A (en) | Hepatitis c virus | |
PL324906A1 (en) | Vaccines against viral hepatitis of c type | |
SG102092G (en) | Hepatitis c virus | |
HU910069D0 (en) | Process for the production of non-a, non-b hepathitis virus genomial dna and antigene polypeptide | |
HUT58371A (en) | Recombinant virus of marek-disease | |
EP1037974A4 (fr) | Proteine tronquee du virus ns5b de l'hepatite c et procedes associes d'identification de composes antiviraux | |
GB2108527B (en) | Non-a non-b hepatitis virus | |
AU7326494A (en) | Nucleotide sequences and process for amplifying and detection of hepatitis b virus | |
EP0585549A3 (en) | Method for producing ectoprotein of hepatitis c virus | |
EP0747482A3 (fr) | Protéines récombinantes de virus de l'hépatite GB et leur utilisations | |
AU4193789A (en) | Detection of non-a, non-b hepatitis | |
AP9300513A0 (en) | Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv) | |
EP0503950A3 (en) | Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells | |
IL90408A0 (en) | Method for producing non-hyperglycosylated hepatitis b virus proteins | |
HU9303066D0 (en) | Particle forming multiply hepatitis b virus surface proteins | |
ZA964094B (en) | Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv) | |
EP0468702A3 (en) | Novel process for purification of hepatitis-a virus capsids | |
AU3914185A (en) | Detection of non-a non-b hepatitis | |
AU688259B2 (en) | Hepatitis C virus peptides | |
IL118364A0 (en) | A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus | |
GB9425604D0 (en) | Peptides effective for diagnsis of hepatitis C infection | |
GB8927844D0 (en) | Process for producing non-structural protein of japanese encephalitis virus |